M. A. Marucci, D. W. Lechner, and B. A. Tafuto, “Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review”, GIT, vol. 2, no. 1, Mar. 2024.